Skip to main content
. Author manuscript; available in PMC: 2016 Jan 11.
Published in final edited form as: Ann Neurol. 2009 Apr;65(4):386–393. doi: 10.1002/ana.21675

Table 1.

Baseline Clinical Features

VEGF (n=39) Placebo (n=11)
Age (Mean, s.d.) 61.4 +/− 9.9 65.6 +/− 8.4
Male 18 (46%) 1 (9%)
Diabetes Type I 7 (18%) 0
Diabetes Type II 32 (82%) 11 (100%)
Diabetes Duration (yrs) 12.7 +/− 10.6 13.2 +/− 7.4
Insulin use 17 (44%) 7 (64%)
Hgb A1C baseline 7.6 +/− 1.4 7.6 +/− 2